Medical Condition News

RSS

Albert Einstein researcher receives Medal of Honor from American Cancer Society

Albert Einstein College of Medicine of Yeshiva University researcher Jeffrey Pollard, Ph.D., has received the prestigious Medal of Honor in Basic Science from the American Cancer Society (ACS) in recognition of his research into the critical role the tumor microenvironment plays in modulating cancer behavior, specifically the role that members of the innate immune cells called macrophages play both in normal development and in promoting tumor progression. These macrophages could hold the key to more targeted cancer treatments.

10 Nov 2010

Enrollment complete in Nabi's second NicVAX Phase III clinical trial for nicotine addiction

Nabi Biopharmaceuticals announced today that it has completed enrollment in the second Phase III clinical trial of NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary investigational candidate vaccine being developed to treat nicotine addiction and prevent smoking relapse.

10 Nov 2010

Senior Scientific receives QTDP grants for cancer detection and treatment

Manhattan Scientifics, Inc. (OTCBB: MHTX) announced that Senior Scientific LLC is the recipient of four grants totaling $702,899 awarded by the Qualifying Therapeutic Discovery Grant Program.

10 Nov 2010

FlexStent Femoropopliteal SE Stent System FIM study results presented at VIVA conference

Final first-in-man (FIM) clinical results on the use of the FlexStent® Femoropopliteal SE Stent System were presented recently at the VIVA conference in Las Vegas by Dr. Andrew Holden of Auckland City Hospital. The clinical results originated from Flexible Stenting Solutions, Inc.'s (FSS) FIM study conducted in New Zealand by Principle Investigator Dr. Andrew Holden, and FSS's supplementary study conducted in Germany by Principle Investigator Dr. Dierk Scheinert of University of Leipzig - Heart Center.

10 Nov 2010

Affluent people face higher risk of melanoma

According to scientists at the Cancer Prevention Institute of California (CPIC), affluent people are at a much higher risk of melanoma than the rest of the population of whites in California.

10 Nov 2010

Common foot disorders more prevalent among African Americans

Common foot disorders such as flat feet, corns and bunions are more prevalent among African Americans than in whites, a new study by University of North Carolina at Chapel Hill researchers has found.

10 Nov 2010

Younger patients unable to cope with pain and emotional issues of cancer

Younger adult cancer patients have the most difficulty coping with the pain and emotional issues of cancer, in spite of their potentially better survival odds, according to a University of Michigan Health System study.

10 Nov 2010

MicroAire and Arthrex enter agreement to settle ECTR patent infringement suit

MicroAire Surgical Instruments LLC and Arthrex Inc. announced today that they have entered an agreement to settle a suit accusing Arthrex of patent infringement and breach of contract. At issue was the patented technology that MicroAire owns for minimally invasive treatment of Carpal Tunnel Syndrome.

10 Nov 2010

Boston Scientific announces first implantation of Vercise Deep Brain Stimulation System in Parkinson's disease trial

Boston Scientific Corporation today announced the first implantation of its Vercise™ Deep Brain Stimulation (DBS) System as part of the VANTAGE clinical trial. VANTAGE is a multi-center, prospective trial designed to examine the improvement of motor function in approximately 40 European patients implanted with the Vercise DBS System for the treatment of Parkinson's disease.

10 Nov 2010

NeuroDerm commences enrollment in ND0801 Phase 2a clinical study of ADD/ADHD in adults

NeuroDerm, Ltd. announced today that patient enrollment has begun in a Phase 2a clinical study of ND0801, a new product for the treatment of Attention Deficit Disorder/Attention Deficit Hyperactivity Disorder (ADD/ADHD) in adults. ND0801, based on a new, proprietary combination with nicotinic actions, is being developed as a dermal patch and will be evaluated for the treatment of cognitive impairment in several disorders including Alzheimer's disease, schizophrenia and advanced Parkinson's disease, among others.

9 Nov 2010

EntreMed to present data of ENMD-2076 Phase 1 study in multiple myeloma and leukemia at ASH 2010

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, today announced presentations for its Phase 2 oncology drug candidate, ENMD-2076. Data for the ENMD-2076 Phase 1 studies in multiple myeloma and leukemia will be presented by EntreMed investigators at the 2010 Annual Meeting of the American Society of Hematology (ASH) to be held December 4-7 at the Orange County Convention Center in Orlando, Florida.

9 Nov 2010

Amount of healthy foods must be adapted to limit weight gain

Overweight children reported more frequent intake of healthy foods such as fruit, vegetables, fish, brown bread and potatoes as well as low-energy cheese and yoghurt compared with normal weight children.

9 Nov 2010

Semafore's SF1126 for B-cell chronic lymphocytic leukemia granted FDA orphan drug designation

Semafore Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the Company's SF1126 product candidate for the treatment of B-cell chronic lymphocytic leukemia (CLL). In April 2010, the Company initiated an expansion of its ongoing Phase I clinical study into this disease setting. SF1126 is a novel peptidic prodrug that converts to LY294002, one of the most widely studied small molecule inhibitors of both phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin (mTOR).

9 Nov 2010

Provectus holds second meeting with Australian TGA to review approval of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, has held its second meeting with the Australian Therapeutic Goods Administration ("TGA") to discuss milestones for approval of PV-10 for treatment of metastatic melanoma. The TGA is the part of the Australian Government's Department of Health and Ageing responsible for the assessment, approval and monitoring of therapeutic goods available in Australia. The initial meeting with the TGA was held in October 2008.

9 Nov 2010

Human blood from adult human skin

In an important breakthrough, scientists at McMaster University have discovered how to make human blood from adult human skin.

9 Nov 2010

Study finds lack of medication adherence among people with RA and lupus

People with rheumatic diseases don't take their medication on a regular basis, and this leads to poor outcomes in their disease treatment, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.

9 Nov 2010

Study says looking older does not necessarily point to poor health

Even though most adults want to avoid looking older than their actual age, research led by St. Michael's Hospital shows that looking older does not necessarily point to poor health. The study found that a person needed to look at least 10 years older than their actual age before assumptions about their health could be made.

9 Nov 2010

Patients with germinal center-like structures face greater risk of developing non-Hodgkin's lymphoma

Biopsying the glands that produce saliva to test for germinal center-like formation when someone is diagnosed with primary Sjögren's Syndrome can predict later development of non-Hodgkin's lymphoma, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Atlanta.

9 Nov 2010

Study finds cancer cells subject to several major chromosomal changes at the same time

New progress has been made on the road to understanding the origins of genetic changes in tumour cells. The prevalent theory has been that genetic changes in tumour cells come about in multiple stages over a long time. However, a recent study by researchers at Lund University shows that this does not have to be the case at all, but that the cancer cells instead can be subject to several major chromosomal changes at the same time.

9 Nov 2010

REF donates $24 million in innovative RA research

The American College of Rheumatology Research and Education Foundation today announced it has raised nearly $28 million, and funded $24 million, in RA research through its Within Our Reach: Finding a Cure for Rheumatoid Arthritis campaign - putting the Foundation two million from its initial $30 million goal.

9 Nov 2010

Medical Condition News

Albert Einstein researcher receives Medal of Honor from American Cancer Society

Enrollment complete in Nabi's second NicVAX Phase III clinical trial for nicotine addiction

Senior Scientific receives QTDP grants for cancer detection and treatment

FlexStent Femoropopliteal SE Stent System FIM study results presented at VIVA conference

Affluent people face higher risk of melanoma

Common foot disorders more prevalent among African Americans

Younger patients unable to cope with pain and emotional issues of cancer

MicroAire and Arthrex enter agreement to settle ECTR patent infringement suit

Boston Scientific announces first implantation of Vercise Deep Brain Stimulation System in Parkinson's disease trial

NeuroDerm commences enrollment in ND0801 Phase 2a clinical study of ADD/ADHD in adults

EntreMed to present data of ENMD-2076 Phase 1 study in multiple myeloma and leukemia at ASH 2010

Amount of healthy foods must be adapted to limit weight gain

Semafore's SF1126 for B-cell chronic lymphocytic leukemia granted FDA orphan drug designation

Provectus holds second meeting with Australian TGA to review approval of PV-10 for metastatic melanoma

Human blood from adult human skin

Study finds lack of medication adherence among people with RA and lupus

Study says looking older does not necessarily point to poor health

Patients with germinal center-like structures face greater risk of developing non-Hodgkin's lymphoma

Study finds cancer cells subject to several major chromosomal changes at the same time

REF donates $24 million in innovative RA research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News